• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性心血管风险:动脉僵硬度和左心室重构作为隐匿性高血压的潜在指标

Hidden Cardiovascular Risk: Arterial Stiffness and Left Ventricular Remodeling as Potential Indicators of Masked Hypertension.

作者信息

Zhu Chengjie, Lei Yanna, Kumar Vipin, Yue Xueling, Cui Qingsong, Cheng Xian Wu

机构信息

Intensive Care Unit, Yanbian University Hospital, Yanji, Jilin, P.R. China.

Department of Cardiology and Hypertension, Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, Jilin, P.R. China.

出版信息

J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70077. doi: 10.1111/jch.70077.

DOI:10.1111/jch.70077
PMID:40685757
Abstract

Masked hypertension (MH), characterized by normal office blood pressure (OBP) but elevated out-of-office readings, carries significant cardiovascular risks comparable to those of sustained hypertension, but remains difficult to detect in clinical practice. This review examines the emerging evidence on screening for MH, highlighting recent findings from the PAMELA study demonstrating the clinical utility of combined vascular and cardiac assessments for the detection of MH. Particularly noteworthy is the observation that patients with both an elevated cardiac-ankle vascular index (CAVI) and left ventricular hypertrophy (LVH) or concentric remodeling had a 2.3-fold increased risk of MH, particularly in men, independent of age and antihypertensive treatment. CAVI offers distinct advantages as a screening parameter due to its independence from blood pressure fluctuations during measurement, its established prognostic value for cardiovascular outcomes, and its high reproducibility in primary care. We propose a stepwise screening approach, prioritizing CAVI assessment in patients with normal OBP but multiple cardiovascular risk factors, followed by echocardiographic assessment in those with elevated CAVI values. This strategy may facilitate earlier detection of MH, allowing timely intervention to reduce cardiovascular morbidity and mortality, although further validation in different age groups and cost-effectiveness analyses are warranted.

摘要

隐匿性高血压(MH)的特征是诊室血压(OBP)正常但诊室外血压读数升高,其心血管风险与持续性高血压相当,但在临床实践中仍难以检测。本综述探讨了有关筛查MH的新证据,重点介绍了PAMELA研究的最新发现,该研究证明了联合血管和心脏评估对检测MH的临床实用性。特别值得注意的是,心脏-踝部血管指数(CAVI)升高且伴有左心室肥厚(LVH)或向心性重塑的患者发生MH的风险增加了2.3倍,尤其是男性,且独立于年龄和抗高血压治疗。CAVI作为一种筛查参数具有明显优势,因为它在测量过程中不受血压波动的影响,对心血管结局具有既定的预后价值,并且在初级保健中具有很高的可重复性。我们提出一种逐步筛查方法,优先对OBP正常但有多种心血管危险因素的患者进行CAVI评估,然后对CAVI值升高的患者进行超声心动图评估。尽管需要在不同年龄组中进行进一步验证和成本效益分析,但该策略可能有助于更早地检测出MH,从而及时进行干预以降低心血管发病率和死亡率。

相似文献

1
Hidden Cardiovascular Risk: Arterial Stiffness and Left Ventricular Remodeling as Potential Indicators of Masked Hypertension.隐匿性心血管风险:动脉僵硬度和左心室重构作为隐匿性高血压的潜在指标
J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70077. doi: 10.1111/jch.70077.
2
Impact of Arterial Stiffness on Cardiac Geometry.动脉僵硬度对心脏几何结构的影响。
Int Heart J. 2025;66(3):449-455. doi: 10.1536/ihj.24-727.
3
Predictive significance of cardio ankle vascular index for the assessment of cardiovascular risk in hypertensive patients: A systematic review.心踝血管指数对高血压患者心血管风险评估的预测意义:系统评价。
J Clin Hypertens (Greenwich). 2024 Sep;26(9):1005-1014. doi: 10.1111/jch.14878. Epub 2024 Aug 22.
4
Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.儿童隐匿性高血压的患病率及亚临床心血管结局风险:系统评价和荟萃分析。
Hypertension. 2023 Nov;80(11):2280-2292. doi: 10.1161/HYPERTENSIONAHA.123.20967. Epub 2023 Sep 22.
5
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
6
Pharmacotherapy for hypertension-induced left ventricular hypertrophy.高血压性左心室肥厚的药物治疗。
Cochrane Database Syst Rev. 2021 Oct 10;10(10):CD012039. doi: 10.1002/14651858.CD012039.pub3.
7
Impact of vascular biomarkers and supine hypertension on cardiovascular outcomes in hypertensive patients: first results from the Cardiovascular Prognostic COUPLING Study in Japan.血管生物标志物和卧位高血压对高血压患者心血管结局的影响:日本心血管预后耦合研究的初步结果
Hypertens Res. 2025 Feb;48(2):693-701. doi: 10.1038/s41440-024-01922-1. Epub 2024 Oct 12.
8
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
9
Ambulatory Blood Pressure Phenotypes, Arterial Stiffness, and Cardiac Remodeling.动态血压表型、动脉僵硬度和心脏重构。
Am J Hypertens. 2024 Nov 15;37(12):978-986. doi: 10.1093/ajh/hpae106.
10
Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.新发心房颤动患者的超声心动图:系统评价和经济评估。
Health Technol Assess. 2013 Aug;17(36):1-263, v-vi. doi: 10.3310/hta17360.

本文引用的文献

1
Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population.动脉僵硬度增加和左心室重塑作为隐匿性高血压的标志物:来自帕梅拉人群的研究结果。
J Hypertens. 2025 May 1;43(5):781-789. doi: 10.1097/HJH.0000000000003970. Epub 2025 Jan 22.
2
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
3
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.
2024年欧洲高血压学会动脉高血压管理临床实践指南
Eur J Intern Med. 2024 Aug;126:1-15. doi: 10.1016/j.ejim.2024.05.033. Epub 2024 Jun 24.
4
Cardio-ankle vascular index for predicting cardiovascular morbimortality and determinants for its progression in the prospective advanced approach to arterial stiffness (TRIPLE-A-Stiffness) study.心血管踝臂指数预测心血管发病率和死亡率及其在动脉僵硬度前瞻性高级研究(TRIPLE-A-Stiffness 研究)中进展的决定因素。
EBioMedicine. 2024 May;103:105107. doi: 10.1016/j.ebiom.2024.105107. Epub 2024 Apr 17.
5
Derivation of an Outcome-Driven Threshold for Aortic Pulse Wave Velocity: An Individual-Participant Meta-Analysis.基于个体参与者的荟萃分析:为主动脉脉搏波速度制定一个结果驱动的阈值。
Hypertension. 2023 Sep;80(9):1949-1959. doi: 10.1161/HYPERTENSIONAHA.123.21318. Epub 2023 Jul 20.
6
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
7
Hypertensive heart disease: risk factors, complications and mechanisms.高血压性心脏病:危险因素、并发症及机制
Front Cardiovasc Med. 2023 Jun 5;10:1205475. doi: 10.3389/fcvm.2023.1205475. eCollection 2023.
8
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.临床和动态血压与死亡率的关系:59124 例患者的观察性队列研究。
Lancet. 2023 Jun 17;401(10393):2041-2050. doi: 10.1016/S0140-6736(23)00733-X. Epub 2023 May 5.
9
Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病儿童和青年中隐匿性高血压的患病率及其与左心室肥厚的关联:一项系统评价和荟萃分析
J Hypertens. 2023 May 1;41(5):699-707. doi: 10.1097/HJH.0000000000003402. Epub 2023 Mar 1.
10
Sex and gender in hypertension guidelines.高血压指南中的性别与性
J Hum Hypertens. 2023 Aug;37(8):654-661. doi: 10.1038/s41371-022-00793-8. Epub 2023 Jan 10.